Do Probiotics Improve IVF and Pregnancy Success Rates?

For couples dealing with infertility, reproductive specialists are constantly searching for safe and effective adjunct therapies to improve success rates. Consequently, researchers are focused on the microbiome, particularly how oral and vaginal probiotics and pregnancy outcomes correlate during fertility treatments. A healthy genital tract microbiota, dominated by Lactobacillus species, appears essential for optimal embryo implantation. Conversely, bacterial dysbiosis in the vagina can compromise female fertility and reduce the success of assisted reproductive technology. Therefore, a comprehensive systematic review published in June 2026 evaluated the clinical impact of probiotic supplementation in infertile women.

Oral Probiotics and Pregnancy Outcomes: What the Evidence Shows

The meta-analysis compiled data from 16 studies involving 2,339 infertile women. Specifically, the researchers evaluated how oral probiotic supplements affect early reproductive success. The results demonstrated that oral probiotics significantly increased biochemical pregnancy rates, showing a risk ratio of 1.27. Additionally, the clinical pregnancy rate improved substantially, with a risk ratio of 1.71 in the probiotic group. Furthermore, oral supplementation led to higher live-birth rates, achieving a risk ratio of 1.24. These findings suggest that oral administration effectively supports reproductive health, potentially by optimizing the gut-urogenital axis. However, the overall certainty of this evidence remains low to very low.

The Role of Vaginal Probiotics in Reducing Miscarriage

In contrast to oral administration, vaginal probiotics did not show the same broad-spectrum impact on pregnancy rates. Nevertheless, local vaginal therapy demonstrated a highly specific benefit. Specifically, vaginal probiotics significantly reduced the risk of miscarriage, yielding a risk ratio of 0.57. This local therapy likely stabilizes the vaginal microenvironment by directly preventing the ascent of pathogenic bacteria. Consequently, this protective effect helps maintain early pregnancy. Unfortunately, vaginal probiotics did not significantly alter overall clinical or biochemical pregnancy rates in this meta-analysis. Therefore, clinicians must distinguish between the systemic benefits of oral administration and the localized protective effects of vaginal therapy.

Clinical Recommendations for Indian Gynecologists

In India, a high prevalence of reproductive tract infections and vaginal dysbiosis often complicates infertility management. Therefore, Indian gynecologists frequently consider probiotic therapy to restore mucosal health. Although these findings are promising, clinicians must proceed with caution because the certainty of evidence remains low. Consequently, probiotics should complement, not replace, standard protocols in assisted reproductive technology. Additionally, doctors should select specific, well-characterized strains of Lactobacillus to target individual patient needs. Ultimately, we need larger randomized controlled trials to define optimal dosing and treatment durations for Indian women.

Frequently Asked Questions

Q1: How do oral probiotics improve pregnancy rates in infertile women?

Oral probiotics primarily optimize the gut microbiome, which subsequently helps regulate systemic inflammation and immune responses. Consequently, this creates a more receptive uterine environment that significantly supports embryo implantation and early pregnancy development.

Q2: Can vaginal probiotics prevent miscarriage in women undergoing fertility treatment?

Yes, because the local administration of vaginal probiotics directly populates the genital tract with beneficial Lactobacillus species. This local colonization successfully prevents the ascent of pathogenic bacteria. As a result, it reduces vaginal dysbiosis and significantly decreases the risk of early pregnancy loss.

Q3: Should probiotics be routinely prescribed to all infertile women?

Currently, clinicians should not routinely prescribe probiotics as a standalone treatment because the supporting evidence remains of low quality. However, they serve as a safe adjunctive therapy alongside standard treatments, especially for patients with a history of dysbiosis.

References

1. Moradi M et al. Oral and Vaginal Probiotics and Pregnancy Outcomes in Women With Infertility: A Systematic Review and Meta-analysis. Obstet Gynecol. 2026 Jun 18. doi: 10.1097/AOG.0000000000006356. PMID: 42314171.
2. Ghaleno HR et al. Vaginal probiotics as therapeutic adjuncts for improving embryo transfer success rates: a systematic review and meta-analysis. J Assist Reprod Genet. 2024 Oct. doi: 10.1007/s10815-024-03200-x.
3. Moradi A et al. The effect of vitamin D supplementation and vaginal probiotics on fertility in women with recurrent implantation failure: A randomized clinical trial. J Reprod Immunol. 2025 Feb. doi: 10.1016/j.jri.2024.104370.